Biochemistry News and Research

RSS

BU awarded T32 grant to mentor research trainees in lung biology and pulmonary sciences

Boston University School of Medicine's longest NIH-funded research training program, "Biology of the Lung: A Multi-Disciplinary Program," has been awarded a five-year, T32 grant to provide multidisciplinary training and exposure to collaborative lung biology in three scientific areas that are special strengths at Boston University: Development and Regenerative Medicine; Immunology and Infection; and Biomedical Data Sciences.

1 Jul 2021

The impact of COVID-19 on dialysis patients

In this interview, News-Medical speaks to Professor Simon Davies and Dr. Raymond Vanholder about the impact of COVID-19 on kidney dialysis patients.

1 Jul 2021

Study provides renewed hope for treating Alzheimer's and Parkinson's diseases

Nanosized molecules of a particular chemical element can inhibit the formation of plaque in the brain tissues. This new discovery by researchers at Umeå University, Sweden, in collaboration with researchers in Croatia and Lithuania, provides renewed hope for novel treatments of, for instance, Alzheimer's and Parkinson's disease in the long run.

1 Jul 2021

Two CU Cancer Center studies provide insights into the link between inflammation and leukemia

Two recent collaborative publications by CU Cancer Center members provide insights into how chronic inflammation can serve as a key factor in the development of leukemia and other blood cancers.

29 Jun 2021

Novel approach to molecular drug design paves way for promising bladder cancer therapy

A new approach to molecular drug design has yielded a highly promising bladder cancer drug, which induced rapid shedding of tumor cells and resulted in a significant reduction in tumour size when used in clinical trials.

28 Jun 2021

Maternal Omega 3-rich diet may reduce onset of breast cancer in offspring

According to researchers at Marshall University, a maternal diet rich in Omega-3 fatty acids protects from breast cancer development in offspring.

28 Jun 2021

UTHSC researchers publish new findings on how obesity impacts cancer treatments

Liza Makowski, PhD, professor in the Department of Medicine and the UTHSC Center for Cancer Research, has long been interested in how the immune system is altered by obesity and how this impacts cancer risk and treatment.

25 Jun 2021

New 3Cs multiplex technique based on CRISPR-Cas technology helps study cancer mutations

Cancer and many other diseases are based on genetic defects. The body can often compensate for the defect of one gene; it is only the combination of several genetic errors that leads to the clinical picture.

25 Jun 2021

Study reveals a novel trick employed by MRSA superbug to thwart the immune response

New research has uncovered a novel trick employed by the bacterium Staphylococcus aureus to thwart the immune response, raising hopes that a vaccine that prevents deadly MRSA infections is a little closer on the horizon.

25 Jun 2021

Fundamental insights on key protein can help strengthen plants against environmental stress

An international study led by Helmholtz Zentrum München has revealed the structure of a membrane-remodeling protein that builds and maintains photosynthetic membranes. These fundamental insights lay the groundwork for bioengineering efforts to strengthen plants against environmental stress, helping to sustaining human food supply and fight against climate change.

25 Jun 2021

Researchers identify key role of enzyme essential for invasion of the toxoplasmosis parasite

Scientists from the universities of Geneva and Zurich and the PSI have identified the structure and functions of RON13, an enzyme of the toxoplasmosis parasite that is essential for the infectious mechanism in humans.

24 Jun 2021

Study finds nutritional benefits of Connecticut-grown sugar kelp

When most Americans think of seaweed, they probably conjure images of a slimy plant they encounter at the beach. But seaweed can be a nutritious food too.

24 Jun 2021

A study of circulating biomarkers in hospitalized patients infected with SARS-CoV-2 alpha variant

Now, a new study published on the medRxiv* preprint server proposes a rapid method to identify the mutations in B.1.1.7 (N501Y mutation and H69/V70 deletion) and the impact of this variant on various biomarkers in hospitalized patients. This is the first study that correlates the biomarker levels to SARS-CoV-2 variants.

23 Jun 2021

Researchers unravel new mechanism that enables cancer development

Researchers at the University of North Carolina at Chapel Hill and the UNC Lineberger Comprehensive Cancer Center have uncovered a new mechanism that activates specific genes, leading to the development of cancers.

23 Jun 2021

SARS-CoV-2 infection and transmission in the North American deer mouse

A recent study conducted in Canada reports that the North American deer mouse can be infected with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from humans.

23 Jun 2021

Study involving virtual patients is as effective as traditional clinical trials

A study involving virtual rather than real patients was as effective as traditional clinical trials in evaluating a medical device used to treat brain aneurysms, according to new research.

23 Jun 2021

Genome surveillance tool facilitates detection of COVID-19 variants

Swedish researchers have developed COVseq, a SARS-CoV-2 genome tracker that can be produced at a large scale for a small cost.

23 Jun 2021

Protein blueprint may aid in treatments for infertility and help protect future fertility

Researchers at the University of Cincinnati College of Medicine have developed a blueprint for a protein that plays an important role in the development and regulation of reproductive organs.

22 Jun 2021

RDM Positive Impact Foundation funds $1.25 million research project to study SYNGAP1

The RDM Positive Impact Foundation is funding an ambitious $1.25 million research project at the UC Davis MIND Institute to study SYNGAP1.

22 Jun 2021

Bruker’s molecular phenomics research tools enable new insights into ‘long COVID’ and post-acute metabolic abnormalities

A clinical research collaboration on COVID-19 pheno-conversion and subsequent pheno-reversion has discovered transient and persistent systemic changes of the molecular signatures in patient blood samples three months after the acute COVID-19 disease phase.

From Bruker BioSpin Group 22 Jun 2021

Biochemistry News and Research

BU awarded T32 grant to mentor research trainees in lung biology and pulmonary sciences

The impact of COVID-19 on dialysis patients

Study provides renewed hope for treating Alzheimer's and Parkinson's diseases

Two CU Cancer Center studies provide insights into the link between inflammation and leukemia

Novel approach to molecular drug design paves way for promising bladder cancer therapy

Maternal Omega 3-rich diet may reduce onset of breast cancer in offspring

UTHSC researchers publish new findings on how obesity impacts cancer treatments

New 3Cs multiplex technique based on CRISPR-Cas technology helps study cancer mutations

Study reveals a novel trick employed by MRSA superbug to thwart the immune response

Fundamental insights on key protein can help strengthen plants against environmental stress

Researchers identify key role of enzyme essential for invasion of the toxoplasmosis parasite

Study finds nutritional benefits of Connecticut-grown sugar kelp

A study of circulating biomarkers in hospitalized patients infected with SARS-CoV-2 alpha variant

Researchers unravel new mechanism that enables cancer development

SARS-CoV-2 infection and transmission in the North American deer mouse

Study involving virtual patients is as effective as traditional clinical trials

Genome surveillance tool facilitates detection of COVID-19 variants

Protein blueprint may aid in treatments for infertility and help protect future fertility

RDM Positive Impact Foundation funds $1.25 million research project to study SYNGAP1

Bruker’s molecular phenomics research tools enable new insights into ‘long COVID’ and post-acute metabolic abnormalities

Binding kinetics in drug discovery eBook eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo